Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Hodgkin Disease 1Hepatic Malignancies 1Head and Neck Neoplasms 1Glioblastoma 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1Breast Cancer Metastases 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Temozolomide 115Bevacizumab 72Radiotherapy 52Radiation 23Erlotinib Hydrochloride 13Lomustine 12pembrolizumab 11Magnetic Resonance Spectroscopy 11Vorinostat 10Nivolumab 10Surgical Procedures, Operative 9Irinotecan 9Sorafenib 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 7Immunoglobulin G 7Everolimus 7Drug Therapy 7Disulfides 7Radiosurgery 6Granulocyte-Macrophage Colony-Stimulating Factor 6Carmustine 6antineoplaston AS 2-1 5antineoplaston A10 5Sirolimus 5Cilengitide 5veliparib 4veledimex 4temsirolimus 4selinexor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Glioblastoma × Positron Emission Tomography Computed Tomography × Clear all
NCT02410577 2019-03-19

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Memorial Sloan Kettering Cancer Center

Phase NA Completed
2 enrolled 5 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡